Synergetics (SURG) FQ1 results beat on a per share basis, but come up just shy on revenue,...

|About: Synergetics USA, Inc. (SURG)|By:, SA News Editor

Synergetics (SURG) FQ1 results beat on a per share basis, but come up just shy on revenue, despite an 11.6% Y/Y jump in profit. Top line sales benefited from ongoing demand for its ophthalmic and neurosurgical products across all major market segments, particularly in its disposable product unit, which accounted for 82% of the company's total FQ1 sales.